Introduction {#sec1-1}
============

Scrub typhus is the most common rickettsial infection in the Indian subcontinent.\[[@ref1]\] It is a zoonotic illness caused after the bite of a trombiculid mite larva carrying Orientia tsutsugamushi, an obligate intracytosolic bacterium. The mites use rodents as hosts.\[[@ref1]\] In India, the reported incidence of Orientia in rodent carriers is very high.\[[@ref2]\] Epidemics of scrub typhus have been reported in many parts of India, including the sub-Himalayan region.\[[@ref3][@ref4]\] A few studies have also been reported from the state of Uttarakhand,\[[@ref5][@ref6]\] and a sudden outbreak was observed in the year 2013 after the flash floods.\[[@ref5]\] The myriad of nonspecific features involving multiple organ systems, overlooking it as a cause of pyrexia in lieu of other infective etiologies of fever in a tropical country such as India, in addition to the lacunae in diagnostic facilities in the Indian scenario is the major contributor to the resurrection of this disease.

Despite the growing awareness and reported articles, there is paucity of compendious and succinct evidence-based data about the protean manifestations, first-line drugs, optimum duration of treatment, and long-term outcomes related to this disease. This is an attempt to contribute our experiences related to scrub typhus to enhance the database for future references. This study also incorporates comparisons between Indian and other Asian studies, as well as reports the outcomes in six pregnant females with scrub typhus who were enrolled in the study.

Materials and Methods {#sec1-2}
=====================

This was a retrospective observational study, carried out in 2015 in the Department of General Medicine of a large teaching tertiary care institution in Garhwal, Uttarakhand. Case records of 54 IgM ELISA-confirmed cases of scrub typhus admitted in the general medicine ward from January 2014 to December 2014, who met the inclusion and exclusion criteria, were collected and analyzed. These case records were designed to provide pertinent demographic and clinical information including age, gender, occupation, presenting features, examination findings, laboratory results, complications, treatment instituted, and outcomes.

The diagnostic testing was carried out at the general microbiology department of the institute as per the instructions given by the manufacturer. The blood samples were subjected to detection of specific IgM antibodies against the causative agent *Orientia tsutsugamushi* using a commercial ELISA kit (manufactured by InBios International Inc., USA).

Inclusion criteria {#sec2-1}
------------------

Pyrexia for more than 5 daysAge \>18 yearsPositive serology for scrub typhus.

Exclusion criteria {#sec2-2}
------------------

Patients with other established causes of pyrexia, such as malaria, dengue, leptospirosis, enteric fever, and viral meningitisNegative serology for scrub typhusIncomplete case recordsPatient refusal to participate in the study.

The definitions used to describe complications in the study are as follows:

Acute kidney injury (AKI): as per the latest Acute Kidney Injury Network (AKIN) classification guidelines\[[@ref7]\]Acute hepatitis: elevation of serum transaminases \[aspartate aminotransferase (AST)/alanine aminotransferase (ALT)\] more than four times the upper limit of normalAcute respiratory distress syndrome (ARDS): acute-onset noncardiogenic pulmonary edema which manifests with bilateral alveolar or interstitial infiltrates on a chest radiograph, with a PaO~2~/FiO~2~≤200 mmHg on arterial blood gas analysisPneumonia: acute-onset fever and chills with cough/breathlessness, with or without crackles/rhonchi, with radiographic evidence of consolidation or interstitial infiltratesMyocarditis: chest complaints such as pain, breathlessness, or palpitations with electrocardiographic evidence of either diffuse ST elevation or T wave inversion, with elevated markers of myocardial damage: creatine kinase-MB/troponinMeningitis: fever with altered mental status, with or without nausea/vomiting, having signs of meningeal irritation and an abnormal cerebrospinal fluid (CSF) analysisHepatic encephalopathy: acute hepatitis with an altered level of consciousness with overt signs of liver failure.

This study was conducted after clearance from the institutional ethics committee.

Results {#sec1-3}
=======

Demographic characteristics {#sec2-3}
---------------------------

The mean age of the patients was 30.80 ± 12.32 years \[[Table 1](#T1){ref-type="table"}\]. The female-to-male ratio was 2.8:1. The maximum number of cases, that is, 35 (64.82%), belonged to the 20--40 years age group. Most of the afflicted patients belonged to a rural background with a history of working in open fields. Housewives and students constituted the two major occupational subgroups. Most cases were seen in the months of monsoon and the postmonsoon period, that is, July, August, and September.

###### 

A table summarising the demographic variables of the study subjects

  Variable      No. of cases   Percentage
  ------------- -------------- ------------
  Gender                       
   Male         14             25.92
   Female       40             74.08
  Age (years)                  
   \<20         7              12.96
   20-40        35             64.82
   \>40         12             22.22
  Occupation                   
   Housewives   28             51.85
   Farmers      6              11.11
   Students     15             27.77
   Others\*     5              9.25

\*Businessman, army, teacher, guard, laborer

Clinical profile {#sec2-4}
----------------

All the patients presented with pyrexia, with an average duration of illness being 9.8 ± 4 days \[Graphs [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}\]. The most common symptoms in our study were gastrointestinal (GI) and/or respiratory in origin. Fourteen (25.9%) patients presented with altered sensorium, of which 4 (22.22%) developed seizures during their hospital stay. In our study, six (11.11%) patients were pregnant when they acquired scrub typhus (two in the first trimester, one in the second trimester, and three in the third trimester). There were a few unusual presentations documented: two (3.70%) patients presented with hepatic encephalopathy in the emergency department, one (1.85%) patient had signs and symptoms suggestive of pneumonia, while two patients (3.70%) had complaints of dysuria.

![A graph summarising the symptoms at presentation observed in the study subjects](JFMPC-8-1189-g001){#F1}

![A graph summarising the signs observed in the study subjects](JFMPC-8-1189-g002){#F2}

The most common examination finding observed in our study was upper eyelid edema (*n* = 40, 74.07%). The findings considered more suggestive of a rickettsial infection, that is, eschar and skin rash, were found only in (*n* = 7) 12.96% and (*n* = 17) 31.48% of cases, respectively. The most common site of eschar in our study was the abdomen (*n* = 4, 57.14%) at the site where the saree is tied \[[Figure 1](#F3){ref-type="fig"}\]. Other sites where the eschar was seen were perineum \[[Figure 2](#F4){ref-type="fig"}\], leg, and arm. There was no difference among clinical presentation and severity of illness between pregnant and nonpregnant female patients.

![A figure demonstrating an eschar at abdomen](JFMPC-8-1189-g003){#F3}

![A figure demonstrating an eschar at perineum](JFMPC-8-1189-g004){#F4}

Laboratory results {#sec2-5}
------------------

Four patients (7.40%) developed acute hepatitis \[[Graph 3](#F5){ref-type="fig"}\]. Lumbar puncture was performed in 14 suspected cases of CNS involvement, of which 6 cases (42.8%) had elevated protein and lymphocytic preponderance on CSF examination. Contrast-enhanced computed tomography was performed in 10 cases, which suggested the nonspecific finding of effacement of the sulci in 2 cases. Abdominal sonography showed hepatomegaly in eight cases (14.8%) and splenomegaly in one case (1.85%). None of the patients showed any alteration of hepatic echotexture or obstructive features in ultrasonography. Urine routine/microscopic examination was abnormal in two cases (3.70%) showing elevated pus cells, with no other abnormality. Chest radiographs showed pleural effusion in 1.85% (*n* = 1) of case, opacities in 18.5% (*n* = 10), ARDS in 7.40% (*n* = 4), and peribronchial thickening in 9.2% (*n* = 5) of cases. Electrocardiography was performed for 10 patients but revealed no abnormalities in any of them.

![A graph summarising the laboratory abnormalities observed in the study subjects](JFMPC-8-1189-g005){#F5}

Treatment and outcomes {#sec2-6}
----------------------

A total of 48 patients were treated with supportive care and a medical regimen consisting of twice-daily oral doxycycline (100 mg). Of them, 12 patients (22.22%) developed nausea/vomiting and were switched over to once-daily oral azithromycin (500 mg). Six pregnant patients in our study were started on oral azithromycin 500 mg OD. The treatment was administered for 5 days in uncomplicated cases and for 10 days in patients with complications. Two patients developed Stage 2 AKI (as per AKIN classification),\[[@ref7]\] and four developed ARDS during their hospital stay. Of a total of 54 patients, 53 recovered, while 1 patient died of ARDS. Comparison with other studies is summarized in Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}.

###### 

A table of comparison of clinical presentations and complications observed in our study compared to studies done in other parts of India

                                          Vivekanandan *et al*.\[[@ref8]\]   Subbalaxmi *et al* \[[@ref9]\]   Sivarajan *et al*.\[[@ref10]\]                   Takhar *et al*.\[[@ref11]\]   This study \[Graphs [1](#F1){ref-type="fig"}--[3](#F5){ref-type="fig"}\]
  --------------------------------------- ---------------------------------- -------------------------------- ------------------------------------------------ ----------------------------- --------------------------------------------------------------------------
  Place; sample size                      Puducherry; 50                     Andhra Pradesh; 176              Meghalaya; 90                                    Rajasthan; 66                 Uttarakhand; 54
  Clinical features                                                                                                                                                                          
   Fever                                  50 (100%)                          176 (100%)                       75 (83.3)                                        66 (100%)                     54 (100%)
   Myalgia                                19 (38%)                           NA                               56 (62.2)                                        20 (30.3%)                    40 (74.07%)
   Altered sensorium                      10 (20%)                           23 (13.1%)                       5 (19%)                                          26 (39.4%)                    14 (25.92%)
   Headache                               20 (40%)                           92 (52.3%)                       24 (26.7)                                        22 (33.3%)                    45 (83.33%)
   Cough                                  20 (40%)                           94 (53.4%)                       21 (23.3)                                        32 (48.5%)                    28 (51.85%)
   Nausea/vomiting                        29 (58%)                           NA                               21 (23.3)                                        18 (27.3%)                    29 (53.7%)
   Abd. pain                              10 (20%)                           NA                               24 (26.7)                                        NA                            39 (72.22%)
   Loose stools                           8 (16%)                            28 (15.9%)                       NA                                               NA                            5 (9.25%)
   Hepatosplenomegaly                     24 (48%)                           51 (28.9%)                       Hepatomegaly 24 (26.7), splenomegaly 22 (24.4)   23 (34.8%)                    Hepatomegaly 10 (18%), splenomegaly 4 (7.4%)
   Eschar                                 23 (46%)                           23 (13.1%)                       10 (11.1)                                        8 (12.1%)                     7 (12.96%)
   Upper lid edema                        NA                                 NA                               NA                                               NA                            40 (74.07)
   Conjunctival congestion/hemorrhage     NA                                 NA                               NA                                               NA                            3 (5.55%)
  Complications                                                                                                                                                                              
   Leukopenia (\<4000/mm^3^)              1 (2%)                             42 (23.9%)                       11 (12%)                                         10 (15.1%)                    1 (1.87%)
   Leucocytosis (\>11,000/mm^3^)          15 (30%)                           18 (10.2%)                       23 (25%)                                         20 (30.3%)                    16 (29.62%)
   Thrombocytopenia (\<100,000/mm^3^)     5 (10.8%)                          53 (30.1%)                       18 (20%)                                         52 (78.8%)                    7 (12.9%)
   Raised transaminases                   47 (95.9%)                         153 (86.9%)                       ALT 85 (94%), AST 90 (100%)                     32 (48.5%)                    40 (74.07%)
   Renal failure (criteria not defined)   6 (12%)                            49 (27.8%)                       11 (12.2%)                                       34 (51.5%)                    2 (3.70%)
   Mortality                              1 (2%)                             8 (4.5%)                         5 (5.15%)                                        21.2%                         1 (1.87%)

ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; NA: Data not available

###### 

A table of comparison of clinical presentations and complications observed in our study compared to studies done in other Asian countries

                                        Zhang et al.\[[@ref12]\]                         Kun Ming Wu et al.\[[@ref13]\]   Hamaguchi et al.\[[@ref14]\]     Brummaier et al.\[[@ref15]\]   This study \[Graphs [1](#F1){ref-type="fig"}--[3](#F5){ref-type="fig"}\]
  ------------------------------------- ------------------------------------------------ -------------------------------- -------------------------------- ------------------------------ --------------------------------------------------------------------------
  Place; sample size                    Shandong; 102                                    Taiwan; 136                      Hanoi, Vietnam; 237              North-western Thailand; 422    Uttarakhand, India; 54
  Clinical features                                                                                                                                                                       
   Fever                                102 (100%)                                       134 (98.5%)                      180 (76%)                        378 (89.6%)                    54 (100%)
   Relative bradycardia                 NA                                               NA                               92 (39.8%)                       NA                             12 (22.22%)
   Headache                             64 (62.7%)                                       85 (62.5%)                       167 (70.5%)                      224 (53.1%)                    45 (83.33%)
   Myalgia                              48 (47.1%)                                       NA                               161 (67.9%)                      151 (35.8%)                    40 (74.07%)
   Altered mental status                NA                                               NA                               23 (9.7%)                        7 (1.7%)                       14 (25.92%)
   Abdt tenderness                      17 (16.7%)                                       42 (30.9%)                       10 (4.3%)                        98 (23.2%%)                    29 (53.7%)
   Nausea/vomiting                      28 (27.4%)                                       NA                               NA                               85 (20.1%)/116 (27.5%)         29 (53.70%)
   Cough                                14 (13.7%)                                       71 (52.5%)                       104 (43.9%)                      115 (27.3%)                    28 (51.85%)
   Conjunctival congestion/hemorrhage   8 (7.8%)                                         NA                               NA                               NA                             3 (5.55%)
   Eschar                               88 (86.3%)                                       82 (60.3%)                       149 (62.9%)                      38                             7 (12.96%)
   Rash                                 70 (68.6%)                                       35 (25.7%)                       74 (31.2%)                                                      17 (31.48%)
   Hepatosplenomegaly                   Hepatomegaly 7 (6.9%), splenomegaly 14 (13.7%)   Hepatosplenomegaly 35 (34.7%)    Hepatosplenomegaly 118 (49.8%)   NA                             Hepatomegaly 10 (18.51%), splenomegaly 4 (7.40%)
   Upper eyelid edema                   NA                                               NA                               NA                               NA                             40 (74.07%)
  Complications                                                                                                                                                                           
   Hepatitis                            4 (3.9%)                                         NA                               NA                               1 (0.3%)                       4 (7.40%)
   Bronchopneumonia                     22 (21.6%)                                       13 (20.6%)                       83 (35%)                         30 (9.9%)                      1 (1.87%)
   Pleural effusion                     1 (1%)                                           27 (42.9%)                       NA                               NA                             1 (1.87%)
   Renal failure                        0                                                9 (6.8%)                         19 (11.5%)                       8 (2.6%)                       2 (3.70%)
   ARDS                                 NA                                               4 (6.3%)                         1 (0.4%)                         NA                             4 (7.4%)
   Meningitis                           0                                                NA                               NA                               4 (1.3%)                       11 (20.3%)
   Leucocytosis                         13.5%                                            39 (29.8%)                       96 (40.7%)                       NA                             16 (29.6%)
   Leukopenia                           4.1%                                             NA                               NA                               NA                             1 (1.87%)
   Thrombocytopenia                     25.4%                                            NA                               104 (45%)                        NA                             7 (12.96%)
   Elevated AST                         75%                                              NA                               NA                               74 (24.4%)                     40 (74.07%)
   Elevated ALT                         80.3%                                            109/127 (85.8%)                  194 (97.5%)                                                     39 (72.22%)
   Elevated BUN                         5.7%                                             NA                               82 (36.4%)                                                      47 (87.03%)
   Mortality                            NA                                               2 (1.47%)                        1 (0.4%)                                                        1 (1.87%)

NA: Data not available; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ARDS: Acute respiratory distress syndrome; BUN: Blood urea nitrogen

Discussion {#sec1-4}
==========

Orientia tsutsugamushi, the causative agent, has \>20 antigenically distinct serotypes due to a wide variation in the antigenic protein --56 kDa TSA which is the most abundant protein of *Orientia* genus.\[[@ref1][@ref16]\] This serotypal variability contributes to the wide variability in disease severity and disease presentation of scrub typhus.

Young adults (20--40 years) were the most affected group \[[Table 1](#T1){ref-type="table"}\], which is due to the increased time spent outdoors. Female preponderance was seen \[[Table 1](#T1){ref-type="table"}\], which was in concordance with other risk factor assessment studies.\[[@ref17]\] This is because in hilly areas, it is usually the women who search for and bring firewood from the forests, along with contribution in domestic farming activities. The maximum burden of cases was seen during the monsoon months of July, August, and September, which correlates with other studies as well.\[[@ref5]\] This is attributable to the abundant vegetation growth, increased occupational exposure due to the concurrent harvesting season, leading to more people in the fields and for longer periods of the day in the rainy season. Therefore, preventive measures such as personal protective equipment can have a noticeable impact in decreasing the transmission, especially in these areas.

Eschar, which is described as the characteristic lesion, was noted only in seven of our patients \[[Graph 2](#F2){ref-type="fig"}\]. A similar frequency of its occurrence was reported in the other Indian studies \[[Table 2](#T2){ref-type="table"}\]. Cases from other Asian countries usually have a higher incidence of eschar \[[Table 3](#T3){ref-type="table"}\]. This may be due to variability in the infecting serotype in different regions, high skin color in the Indian subcontinent, and high rates of underdetection due to the painless and nonitchy characteristics of the eschar.

Another frequently observed finding documented in our series was edema, in particular upper eye lid edema, facial edema, and pedal edema \[[Graph 2](#F2){ref-type="fig"}\]. This is much more when compared with the prevalence of facial and pedal edema reported in north-east Himalayan studies.\[[@ref18]\] The edema develops due to multiplication of *Orientia* in the endothelial cells of small blood vessels resulting in breaks in the vascular barrier (perivasculitis) and subsequent accumulation of fluid in the interstitial spaces.\[[@ref19]\] A study done on 451 patients depicting ocular changes in scrub typhus described optic nerve and retinal edema but not upper eyelid edema.\[[@ref20]\] In our study, three (5.55%) patients had subconjunctival hemorrhage \[[Figure 3](#F6){ref-type="fig"}\] which is in concordance with the studies by Zhang *et al*.\[[@ref12]\] and Scheie\[[@ref20]\] but has not been described in other Indian studies \[[Table 2](#T2){ref-type="table"}\].

![A figure demonstrating sub-conjunctival haemorrhage in a study subject](JFMPC-8-1189-g006){#F6}

The most predominant organ system involved was GI \[Graphs [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}\]. The findings corroborate well with the ones described in the literature \[Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}\]. The salient differentiating feature of scrub typhus from other causes of infective GI involvement is anicteric hepatitis.\[[@ref21]\] In our study as well as in other reported studies, serum glutamic oxaloacetic transaminase (AST) is more often elevated when compared with serum glutamic pyruvic transaminase (ALT) \[Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}\], indicating that inflammation in scrub typhus is not just limited to the liver but involves other organs as well. A study done by Mokta *et al*. has mentioned scrub typhus to be the most common cause of febrile jaundice in the Himalayan region.\[[@ref22]\]

The pulmonary involvement in our study is low when compared with other Indian and Asian studies \[Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}\]. Similar radiologic findings were observed in a cohort study of 348 patients.\[[@ref23]\] Hence, in endemic areas, a good understanding and familiarity with the various radiologic findings of scrub typhus is essential in identifying pulmonary complications. The CNS findings of altered sensorium, meningitis, seizures with CSF findings of high protein levels, normal glucose, and lymphocytic preponderance were also described in another study done in 37 patients.\[[@ref24]\] This has significant diagnostic implications, as an acute febrile illness with altered sensorium and signs of meningitis with no eschar may prompt the diagnosis of viral meningoencephalitis.

It was reported that serious complications often developed in the second week during the course of untreated illness,\[[@ref25]\] which correlated with our findings: of 20 patients with complications, 13 developed in the second week of illness (65%), and 7 developed in the third week (35%). Nearly all complicated patients usually presented late, with complications already manifesting due to ignorance, illiteracy, and superstitious beliefs in the local population. According to our study, two patients had stage 2 AKI as per AKIN classification,\[[@ref7]\] but none of them required dialysis. Different studies have reported different results \[Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}\]. Some studies in adults have shown AKI in 12%--22% of patients.\[[@ref9]\] In our study, four of our patients developed ARDS while in the hospital. Among them, one died (case-specific mortality = 25%), which is equivalent to a study reported in Taiwan.\[[@ref26]\] Two patients presented to us in the emergency department with overt hepatic failure in the setting of hepatic encephalopathy. A similar prevalence (5.2%) of hepatic encephalopathy has been described by Vikrant *et al*. in the Himalayan region.\[[@ref27]\]

Leucocytosis with lymphocytic preponderance and thrombocytopenia (as in our study) have been noted in studies both from the Indian subcontinent and other Asian endemic zones \[Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}\]. In a study by Varghese *et al*. (*n* = 50), a combination of elevated transaminases, thrombocytopenia and leucocytosis displayed 80% specificity and 80% positive predictive value for scrub typhus diagnosis.\[[@ref28]\] This could be especially useful to primary care physicians in hilly areas like ours, who may not have immediate access to confirmatory tests. However, this association needs to be confirmed by analytical epidemiological studies on larger samples. Favorable maternal and fetal outcomes were observed in our study which was comparable to another study in sub-Himalayan region by Kumar *et al*.\[[@ref29]\] and in contrast to a study done by Rajan *et al*.\[[@ref30]\] This may be due to a less virulent strain and/or earlier immunity due to persistent exposure to the vector in the Himalayan region.

This study was limited by small sample size. The study relied on IgM positivity through ELISA while indirect immunofluorescence assay is considered the gold standard test for scrub typhus diagnosis. (However, a correlation of 97% between IgM ELISA and SD BIOLINE tsutsugamushi rapid test was reported in India.\[[@ref31]\]). In this study, serotyping and genotyping were not performed due a lack of resources.

Scrub typhus should be included in the list of differentials while evaluating a patient of acute undifferentiated febrile illnesses from rural background in a tropical country like India. In conclusion, scrub typhus can have a variety of clinical presentations, and indigenous patients hailing from the hilly regions of Uttarakhand regularly tend to have a less severe course of illness, often without a rash or eschar. Whether this is due to past exposure to the organism, variation in strain type, or other factors needs to be explored. Upper eyelid edema, facial edema, and pedal edema should also be considered as pointers to scrub typhus. The outcomes are better when compared with studies in other places, therefore indicating a less virulent strain and milder disease in the Himalayan regions. Primary care physicians can play a pivotal role to prevent this potentially fatal clinical entity from spiralling into a major public health issue by early recognition and treatment based on clinical presentation and simple laboratory parameters in the absence of gold standard confirmatory tests in resource-poor setting.
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